Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: The incidence and characteristics of adverse events. After: Measure: Number of Participants With Adverse Events Associated With Administration of 0.75 mg/kg of ELX-02 Once Daily.
Participant count type changed
Before: Estimated. After: Actual.
Enrollment · participant count changed
Before: 8 participants (planned). After: 3 participants (actual).
Completion date type changed
Before: Estimated. After: Actual.
Primary completion date changed
Before: 30 May 2023. After: 11 Sep 2023.
Recruitment status changed
Before: Recruiting. After: Completed.